SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-19-013883
Filing Date
2019-09-09
Accepted
2019-09-09 17:15:26
Documents
3
Period of Report
2019-09-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 30391
2 ex99-1.htm EX-99.1 26680
3 ex99-1_001.jpg GRAPHIC 5789
  Complete submission text file 0001493152-19-013883.txt   66385
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16467 | Film No.: 191083748
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1